Coronado Biosciences to Report Fourth Quarter and Full Year 2012 Results

BURLINGTON, Mass., March 7, 2013 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy biologic agents for the treatment of autoimmune diseases and cancer, announced today that it will report its financial results for the fourth quarter and full year 2012, on Thursday, March 14, 2013 at 8:30 AM ET. To participate in the conference call, please dial 877-312-5413 (toll free from the US and Canada), or 253-237-1511 (for international callers). Investors may also access a live audio webcast of the call at www.coronadobiosciences.com on the Events & Webcasts page.

Back to news